Intermittent preventive treatment against malaria: an update.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceThe impact of maternal malaria on newbornsCombination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancySubstantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina FasoIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialProtective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trialIntermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial.Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali.The Malaria in Pregnancy Library: a bibliometric review.Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaIntermittent preventive therapy for malaria: arguments in favour of artesunate and sulphamethoxypyrazine - pyrimethamine combinationThe effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.Malaria and severe anemia: thinking beyond Plasmodium falciparumMolecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola.Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers.Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.Pregnancy malaria: cryptic disease, apparent solution.Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean womenIntermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.Prevalence of gestational, placental and congenital malaria in north-west ColombiaAntiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control.Drug repositioning in the treatment of malaria and TB.Emerging drugs for malaria.The η-class carbonic anhydrases as drug targets for antimalarial agents.Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
P2860
Q21032450-95C649BF-EB1B-49AB-AE66-A6AE5281BA84Q21032461-2D82CBF9-D4FA-4286-BEE2-664BDA9829CBQ27005614-299407EA-E594-45F8-8540-2DA1141FEBB1Q28125898-91B45B1C-79F9-420F-A5A4-6F1E2B9AF41EQ28481649-0D456E6F-6738-4AD1-91AC-5FCE9339D40FQ28541598-535844D8-A657-47A9-BEE2-C388B5B5805EQ33589334-796D177F-90B3-4561-9B44-29A16B0AE986Q33601831-E746873D-8794-4FB9-8065-7E9E6033E1A9Q33728165-309E4CE6-7F9C-48D2-BCED-B32DC82C75E4Q33802641-EBED2AED-B60B-489E-80D9-BC281DA943C2Q34461507-01F292BC-0E43-4B23-B7BF-104913B19A6AQ34596548-5CBDFF0F-CB3E-402B-A78A-DF17701495FDQ34809408-03E7476C-C3F4-4932-B800-70E0881B5D85Q34894294-C94A9368-DEA8-43E4-BAE2-91A3AC4976BEQ35072457-4E02937F-E641-40B5-9D94-040DB07B4D23Q35221902-FA5B2E1D-22EB-4769-A885-A5DDA00F0ECEQ35746024-A4B92CA9-F355-4A1E-BA02-DD85A363E3C6Q35746240-12C55C1E-0CC1-4290-801D-6A991F8DAA77Q36677527-CFCC19A2-F166-4168-A079-EE15B64364F9Q37030663-959BCE7D-28A1-476F-A4B0-2A33312D4EA3Q37287899-5A8D2DC7-4914-4BEA-95B4-A925509BEA3DQ37360711-2ABCE649-1984-477A-84FE-0E88211EBCA7Q37846890-C997C39E-3A6F-414A-8E64-7FA395E454D9Q37924298-F264A99B-DEA0-4DBF-8703-110D4003358EQ38027179-00B7EA7B-BC69-415B-8C3E-328A841D4859Q38286239-99BF060E-EF5F-4302-AC3F-B965007AA088Q38905356-4CC97228-32D4-43E5-90B7-3F1B6A1F2D3D
P2860
Intermittent preventive treatment against malaria: an update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intermittent preventive treatment against malaria: an update.
@en
Intermittent preventive treatment against malaria: an update.
@nl
type
label
Intermittent preventive treatment against malaria: an update.
@en
Intermittent preventive treatment against malaria: an update.
@nl
prefLabel
Intermittent preventive treatment against malaria: an update.
@en
Intermittent preventive treatment against malaria: an update.
@nl
P2093
P2860
P356
P1476
Intermittent preventive treatment against malaria: an update.
@en
P2093
Matthew E Cairns
R Matthew Chico
Roly D Gosling
P2860
P304
P356
10.1586/ERI.10.36
P577
2010-05-01T00:00:00Z